Variant NM_000492.4:c.869+88T>A


Variant details:
Name NM_000492.4:c.869+88T>A
Protein name NP_000483.3:p.(=)
Genomic name (hg19) chr7:g.117176815T>A    UCSC    
#Exon/intron intron 7
Class likely benign
WT sequence TTTATCATGGTAGACTTCCACCTCA T ATTTGATGTTTGTGACAATCAAATG
Mutant sequence TTTATCATGGTAGACTTCCACCTCA A ATTTGATGTTTGTGACAATCAAATG

Other databases:

Not found
Not found		dbSNP
rs79718042







Pathogenicity predictors:

Not found





2 individuals carrying this variant are reported in CFTR-NGS catalogue


1 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 1
Asymptomatic compound heterozygote 1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Asymptomatic compound heterozygote 4737heterozygoteVUS3 - Cis
VUS3 - Trans
VUS3- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare